(Q54600558)

English

HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16715132

HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy. (English)

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16715132

1 reference

based on heuristic

inferred from title

angiogenesis inhibitor

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16715132

author name string

X-F Wen

1

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16715132

G Yang

2

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16715132

W Mao

3

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16715132

A Thornton

4

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16715132

J Liu

5

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16715132

X-F Le

7

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16715132

language of work or name

0 references

publication date

22 May 2006

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16715132

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16715132

25

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16715132

6986-6996

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16715132

52

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16715132

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209685

0 references

Vascular endothelial growth factor up-regulation via p21-activated kinase-1 signaling regulates heregulin-beta1-mediated angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Future options with trastuzumab for primary systemic and adjuvant therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

p38 MAP kinase's emerging role as a tumor suppressor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Different signalling pathways regulate VEGF and IL-8 expression in breast cancer: implications for therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Platinum-taxane combinations in metastatic breast cancer: an evolving role in the era of molecularly targeted therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Vascular endothelial growth factor (VEGF), a survival factor for tumour cells: implications for anti-angiogenic therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

VEGF-Trap: a VEGF blocker with potent antitumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

ErbB receptors: directing key signaling networks throughout life

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Tumour biology: herceptin acts as an anti-angiogenic cocktail.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Combined trastuzumab and paclitaxel treatment better inhibits ErbB-2-mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

The role of HER2 in angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

The role of cyclin-dependent kinase inhibitor p27Kip1 in anti-HER2 antibody-induced G1 cell cycle arrest and tumor growth inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Genes affecting the cell cycle, growth, maintenance, and drug sensitivity are preferentially regulated by anti-HER2 antibody through phosphatidylinositol 3-kinase-AKT signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

ErbB2 overexpression in mammary cells upregulates VEGF through the core promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Signal transduction and oncogenesis by ErbB/HER receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Human neuroblastoma cells produce extracellular matrix-degrading enzymes, induce endothelial cell proliferation and are angiogenic in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

A comparison of the in vitro and in vivo activities of IgG and F(ab')2 fragments of a mixture of three monoclonal anti-Her-2 antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Smad-dependent GADD45beta expression mediates delayed activation of p38 MAP kinase by TGF-beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2/neu gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Overexpression of ErbB2 in cancer and ErbB2-targeting strategies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

21 January 2018

Role of interleukin-8 in tumor growth and metastasis of human melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

Akt takes center stage in angiogenesis signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal antibody therapy for breast cancer: herceptin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: Identification of interleukin-8 as a potential regulatory factor in breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-β1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/neu protein and vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of thrombospondin-1 in tumor progression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

Bispecific minibodies targeting HER2/neu and CD16 exhibit improved tumor lysis when placed in a divalent tumor antigen binding format

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209685

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1209685

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16715132

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16715132

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54600558&oldid=1466376863"